本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Lexeo Therapeutics

2.34
-0.3050-11.55%
盤後2.340.00000.00%17:10 EDT
成交量:54.29萬
成交額:128.75萬
市值:7,751.50萬
市盈率:-0.75
高:2.68
開:2.53
低:2.27
收:2.64
資料載入中...
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

重要事件披露

Form 8-K - Current report
2023/12/18

重要事件披露

Form 8-K - Current report
2023/12/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/11

重要事件披露

Form 8-K - Current report
2023/12/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/25

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/18

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/07

重要事件披露

Form 8-K - Current report
2023/11/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/03

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/11/02

SEC問詢函

Form CORRESP - Correspondence
2023/11/01

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/01

SEC問詢函

Form CORRESP - Correspondence
2023/11/01

SEC問詢函

Form CORRESP - Correspondence
2023/10/30

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/06

SEC問詢函

Form CORRESP - Correspondence